{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:48:21Z","timestamp":1777718901250,"version":"3.51.4"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1093\/jat\/bky053","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T19:15:35Z","timestamp":1531768535000},"page":"554-561","source":"Crossref","is-referenced-by-count":33,"title":["Quantitative Analysis of Novel Synthetic Opioids, Morphine and Buprenorphine in Oral Fluid by LC\u2013MS-MS"],"prefix":"10.1093","volume":"42","author":[{"given":"Michael T","family":"Truver","sequence":"first","affiliation":[{"name":"Department of Forensic Science, Sam Houston State University, 1003 Bowers Blvd., Huntsville, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine J","family":"Swortwood","sequence":"additional","affiliation":[{"name":"Department of Forensic Science, Sam Houston State University, 1003 Bowers Blvd., Huntsville, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"key":"key\n\t\t\t\t2019012508582839200_bky053C1","author":"US Department of Justice Drug Enforcement Agency","year":"2017"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.annemergmed.2016.06.014","article-title":"Fentanyl and a novel synthetic opioid U-47700 masquerading as street \u201cNorco\u201d in central California: a case report","volume":"69","author":"Armenian","year":"2017","journal-title":"Annals of Emergency Medicine"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C3","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1021\/jm00150a017","article-title":"Factors affecting binding of trans-N-(2-(methylamino)cyclohexyl)benzamides at the primary morphine receptor","volume":"28","author":"Cheney","year":"1985","journal-title":"Journal of Medical Chemistry"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C4","first-page":"1","article-title":"Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class","volume":"55","author":"Schneir","year":"2016","journal-title":"Clinical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/15563650.2016.1209767","article-title":"A case of U-47700 overdose with laboratory confirmation and metabolite identification","volume":"55","author":"Jones","year":"2017","journal-title":"Clinical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.forsciint.2016.05.001","article-title":"A case of acute intoxication due to combined use of fentanyl and 3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide (U-47700)","volume":"266","author":"Coopman","year":"2016","journal-title":"Forensic Science International"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/15563650.2016.1209763","article-title":"Two cases of intoxication with new synthetic opioid, U-47700","volume":"55","author":"Domanski","year":"2017","journal-title":"Clinical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jat\/bkx060","article-title":"Multiple drug-toxicity involving novel psychoactive substances, 3-fluorophenmetrazine and U-47700","volume":"41","author":"Ellefsen","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/dta.1984","article-title":"The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide (U-47700) and implications for forensic analysis","volume":"8","author":"Elliott","year":"2016","journal-title":"Drug Testing and Analysis"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jat\/bkx041","article-title":"Qualitative identification of fentanyl analogs and other opioids in postmortem cases by UHPLC-Ion Trap-MSn","volume":"41","author":"Shoff","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C11","first-page":"158","article-title":"A fatality related to the synthetic opioid U-47700: postmortem concentration distribution","volume":"41","author":"McIntyre","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C12","first-page":"709","article-title":"Analysis of novel synthetic opioids U-47700, U-50488 and furanyl fentanyl by LC\u2013MS\/MS in postmortem casework","volume":"40","author":"Mohr","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C13","first-page":"79389","article-title":"Schedules of controlled substances: temporary placement of U-47700 into Schedule I. Final order","volume":"81","author":"US Drug Enforcement Administration","year":"2016","journal-title":"Federal Register"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/dta.2228","article-title":"Metabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug users","volume":"10","author":"Krotulski","year":"2018","journal-title":"Drug Testing and Analysis"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C15","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1093\/jat\/bkx092","article-title":"Fatality following ingestion of tetrahydrofuranylfentanyl, U-49900 and methoxy-phencyclidine","volume":"42","author":"Krotulski","year":"2018","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0022-3565(25)10187-0","article-title":"The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats","volume":"264","author":"Dosaka-Akita","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/dar.12216","article-title":"AH-7921: a new synthetic opioid of abuse","volume":"34","author":"Coppola","year":"2015","journal-title":"Drug & Alcohol Review"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C18","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/jm00257a012","article-title":"1-(3,4-Dichlorobenzamidomethyl)cyclohexyldimethylamine and related compounds as potential analgesics","volume":"17","author":"Harper","year":"1974","journal-title":"Journal of Medicinal Chemistry"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11419-015-0271-z","article-title":"AH-7921: the list of new psychoactive opioids is expanded","volume":"33","author":"Katselou","year":"2015","journal-title":"Forensic Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C20","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.forsciint.2017.04.003","article-title":"Two fatalities associated with synthetic opioids: AH-7921 and MT-45","volume":"277","author":"Fels","year":"2017","journal-title":"Forensic Science International"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C21","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.forsciint.2014.08.013","article-title":"Lethal poisonings with AH-7921 in combination with other substances","volume":"244","author":"Karinen","year":"2014","journal-title":"Forensic Science International"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jat\/bku057","article-title":"Fatal intoxications associated with the designer opioid AH-7921","volume":"38","author":"Kronstrand","year":"2014","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jat\/bku011","article-title":"A fatality involving AH-7921","volume":"38","author":"Vorce","year":"2014","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C24","first-page":"22023","article-title":"Schedules of controlled substances: placement of AH-7921 into Schedule I. Final order","volume":"81","author":"US Drug Enforcement Administration","year":"2016","journal-title":"Federal Register"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/15563650.2014.983239","article-title":"Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45","volume":"53","author":"Siddiqi","year":"2015","journal-title":"Clinical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/15563650.2014.943908","article-title":"MT-45, a new psychoactive substance associated with hearing loss and unconsciousness","volume":"52","author":"Helander","year":"2014","journal-title":"Clinical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C27","doi-asserted-by":"crossref","DOI":"10.4172\/2155-6105.1000287","article-title":"The quest for well-being and pleasure: experiences of the novel synthetic opioids AH-7921 and MT-45, as reported by anonymous users online","author":"Kjellgren","year":"2016","journal-title":"Journal of Addiction Research & Therapy"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jat\/bkw012","article-title":"Analysis of MT-45, a novel synthetic opioid, in human whole blood by LC-MS-MS and its identification in a drug-related death","volume":"40","author":"Papsun","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C29","first-page":"58557","article-title":"Schedules of controlled substances: placement of MT-45 into Schedule I. Final order","volume":"82","author":"US Drug Enforcement Administration","year":"2017","journal-title":"Federal Register"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.annemergmed.2016.08.445","article-title":"Novel synthetic opioids: an opioid epidemic within an opioid epidemic","volume":"69","author":"Lucyk","year":"2017","journal-title":"Annals of Emergency Medicine"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97222","article-title":"Fentanyl-related designer drugs W-18 and W-15 lack appreciable opioid activity in vitro and in vivo","author":"Huang","year":"2017","journal-title":"JCI insight"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C32","article-title":"Order amending Schedules I and III to the Controlled Drugs and Substances Act (AH-7921, MT-45, W-18 and Lefetamine)","year":"2016"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C33","author":"Chan-Hosokawa","year":"2017"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jat\/bkx082","article-title":"Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities\u20142017 update","volume":"42","author":"Logan","year":"2018","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13181-017-0632-6","article-title":"A novel oral fluid assay (LC-QTOF-MS) for the detection of fentanyl and clandestine opioids in oral fluid after reported heroin overdose","volume":"13","author":"Griswold","year":"2017","journal-title":"Journal of Medical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jat\/bkx036","article-title":"Evaluation of oral fluid as a specimen for DUID","volume":"41","author":"Veitenheimer","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jat\/bkx105","article-title":"Field detection of drugs of abuse in oral fluid using the Alere\u2122 DDS\u00ae2 mobile test system with confirmation by liquid chromatography tandem mass spectrometry (LC\u2013MS\/MS)","volume":"42","author":"Krotulski","year":"2018","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00085030.2017.1258212","article-title":"An assessment of oral fluid drug screening devices","volume":"50","author":"Beirness","year":"2017","journal-title":"Canadian Society of Forensic Science Journal"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00216-011-5108-y","article-title":"UHPLC-ESI-MS\/MS method for direct analysis of drugs of abuse in oral fluid for DUID assessment","volume":"401","author":"Strano-Rossi","year":"2011","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/bkt054","article-title":"Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology","volume":"37","author":"Scientific Working Group for Forensic Toxicology","year":"2013","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C41","first-page":"28082","article-title":"Mandatory Guidelines for Federal Workplace Drug Testing Programs","journal-title":"Federal Register"},{"key":"key\n\t\t\t\t2019012508582839200_bky053C42","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jat\/31.8.424","article-title":"Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid","volume":"31","author":"Cone","year":"2007","journal-title":"Journal of Analytical Toxicology"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/42\/8\/554\/26178006\/bky053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T20:58:59Z","timestamp":1751749139000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/42\/8\/554\/5145123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,10,26]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bky053","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10]]},"published":{"date-parts":[[2018,10,1]]}}}